- Home
- TLSI vs DDD Comparison
TLSI vs DDD Comparison
Compare TLSI & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- DDD
- Stock Information
- Founded
- TLSI 2010
- DDD 1986
- Country
- TLSI United States
- DDD United States
- Employees
- TLSI N/A
- DDD N/A
- Industry
- TLSI Medical Specialities
- DDD Computer peripheral equipment
- Sector
- TLSI Health Care
- DDD Technology
- Exchange
- TLSI Nasdaq
- DDD Nasdaq
- Market Cap
- TLSI 244.3M
- DDD 285.8M
- IPO Year
- TLSI N/A
- DDD N/A
- Fundamental
- Price
- TLSI $6.21
- DDD $2.03
- Analyst Decision
- TLSI Strong Buy
- DDD Buy
- Analyst Count
- TLSI 3
- DDD 2
- Target Price
- TLSI $10.67
- DDD $4.75
- AVG Volume (30 Days)
- TLSI 114.0K
- DDD 2.9M
- Earning Date
- TLSI 11-13-2025
- DDD 11-04-2025
- Dividend Yield
- TLSI N/A
- DDD N/A
- EPS Growth
- TLSI N/A
- DDD N/A
- EPS
- TLSI N/A
- DDD 0.10
- Revenue
- TLSI $40,207,000.00
- DDD $391,651,000.00
- Revenue This Year
- TLSI $57.25
- DDD N/A
- Revenue Next Year
- TLSI $54.05
- DDD $1.78
- P/E Ratio
- TLSI N/A
- DDD $19.39
- Revenue Growth
- TLSI 49.52
- DDD N/A
- 52 Week Low
- TLSI $3.42
- DDD $1.32
- 52 Week High
- TLSI $6.36
- DDD $5.00
- Technical
- Relative Strength Index (RSI)
- TLSI 77.66
- DDD 36.41
- Support Level
- TLSI $3.79
- DDD $1.82
- Resistance Level
- TLSI $4.88
- DDD $2.19
- Average True Range (ATR)
- TLSI 0.47
- DDD 0.16
- MACD
- TLSI 0.17
- DDD -0.02
- Stochastic Oscillator
- TLSI 96.84
- DDD 25.90
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.